<DOC>
	<DOCNO>NCT00834626</DOCNO>
	<brief_summary>Ileal interposition shift segment ileum proximally achieve maximal meal stimulate Glucagon-Like Peptide-1 secretion couple limited/complete sleeve gastrectomy ( depend Body Mass Index ) , Ghrelin reduction , help achieve good glycemic control Type 2 Diabetes patient .</brief_summary>
	<brief_title>Ileal Interposition With Sleeve Gastrectomy Control Diabetes</brief_title>
	<detailed_description>Laparoscopically , use 6 port , ileum tarnsected 30 cm proximal ileo-caecal junction 200 cm proximal Ileo-Caecal junction ; ileal segment 170 cm interpose proximal jejunum 20-50 cm distal Ligament Treitz . Endo-GIA stapler hand-sown closure use 3 anastomosis . The mesenteric gap defect close 3/0 prolene suture . Sleeve gastrectomy do start antrum/body upto angle His size bougie range size 32 -- 58 Fr .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>Type 2 Diabetes ( defined American Diabetes Association criterion ) 1 year duration Body Mass Index 21 55 kg/m^2 Poor glycemic control ( HbA1c &gt; 8 % ) despite maximal use Oral Hypoglycemic Agents Insulin ; good control ( low HbA1c ) require progressively high drug dos . Gives Informed Consent surgery Postmeal C peptide &gt; 1.0 ng/mL Age 25 75 year Stable weight 3 month Type 1 Diabetes Postmeal C peptide &lt; 1 ng/mL Pregnancy Significant nephropathy require dialysis Coexisting systemic disease Previous gastric intestinal resection surgery Obesity due organic illness</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Ileal Interposition</keyword>
	<keyword>Sleeve Gastrectomy</keyword>
	<keyword>Type-2 Diabetes</keyword>
</DOC>